{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.90G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P (p.Ala30Pro)"
        },
        {
          "HGVS": "NM_000345.4:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T (p.Ala53Thr)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0004982"
  },
  "Experiment Method": [
    {
      "Assay Method": "PLD2 Inhibition Assay",
      "Material used": {
        "Material Source": "Synthetic Proteins",
        "Material Name": "Synuclein isoforms (wild-type, A30P, A53T) and mutants",
        "Description": "Recombinant synuclein proteins and deletion/phosphorylation mutants tested in vitro."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.90G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "similar to wild-type",
          "Result Description": "A30P mutant exhibited inhibition of PLD2 activity comparable to wild-type synuclein."
        },
        {
          "Variant": "NM_000345.4:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased inhibition",
          "Result Description": "A53T mutant showed significantly higher PLD2 inhibition compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type synuclein used as reference for normal inhibition levels."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Inhibition level equivalent to wild-type synuclein",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Inhibition level significantly higher than wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}